Which hedge funds own TCRX? TSCAN THERAPEUTICS INC, Q2 2026 13F holders
5 of the hedge funds tracked by WhaleCreep disclosed a position in TCRX (TSCAN THERAPEUTICS INC) in their Q2 2026 13F filings, worth $4.6m in total. The largest holder by portfolio weight is Renaissance Technologies LLC at 0.0% of its book.
5tracked managers holding
0opened this quarter
0exited this quarter
Which hedge funds hold TCRX? Current holders by portfolio weight
| Manager | As of | Weight of book | Value | Shares | Δ shares | Action |
|---|---|---|---|---|---|---|
| Renaissance Technologies LLC | Q2 2026 | 0.0% | $1.3m | 1,326,799 | -3% | reduced |
| Millennium Management | Q2 2026 | 0.0% | $1.1m | 1,163,611 | -20% | reduced |
| Marshall Wace | Q2 2026 | 0.0% | $673.6k | 687,364 | 190% | added |
| Citadel Advisors | Q2 2026 | 0.0% | $989.0k | 1,009,107 | 217% | added |
| D. E. Shaw & Co | Q2 2026 | 0.0% | $537.5k | 548,402 | 72% | added |
How has hedge fund ownership of TCRX changed?
| Quarter | Managers holding | Combined value |
|---|---|---|
| Q2 2026 | 5 | $4.6m |
| Q1 2026 | 5 | $3.7m |
| Q4 2025 | 2 | $1.2m |
| Q3 2025 | 1 | $1.5m |
| Q2 2025 | 1 | $1.1m |
| Q1 2025 | 1 | $234.2k |
| Q4 2024 | 2 | $384.5k |
| Q3 2024 | 2 | $909.3k |
| Q2 2024 | 2 | $1.4m |
| Q1 2024 | 1 | $373.0k |
| Q4 2023 | 1 | $127.0k |
| Q3 2023 | 1 | $45.0k |
| Q2 2023 | 1 | $369.0k |
| Q1 2023 | 1 | $24.0k |
| Q4 2022 | 1 | $16.0k |
| Q3 2022 | 1 | $203.0k |
Counts every tracked manager that disclosed TCRX in that quarter's filing, including managers that have since stopped filing.